The sustained success of Eliquis is further supported by its patent protections, which have delayed generic competition in the US until at least 2026, and potentially until 2031
Are GLP-1 Medications Alone Enough to Help You
Por otro lado, el GIP es un pptido de 42 aminocidos secretado por la mucosa gstrica y las clulas K en la mucosa del intestino delgado (duodeno, yeyuno y porcin proximal del leon), el cual tiene un efecto incretina a travs de su receptor, el GIP-R acoplado a protena G 30
Nonetheless, gastrointestinal adverse symptoms (e.g., nausea, vomiting) persist often, and long-term safety data are still being examined
The TRIUMPH-4 study included the standard suicide-risk screening tool (the C-SSRS) and didnt flag a difference between retatrutide and placebo